Treatment and Care
Treatment Centers and Clinical Services
Care Team
Patient And Family Support
Care Quality and Patient Safety
Patient Stories
For Adult Cancer Survivors
Browse by Cancer Type
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

New Patient Guide

Appointments & Second Opinions

New Patient? For appointments or second opinions: Adults: (877) 442-DFCI (442-3324) Children: (888) PEDI-ONC (733-4662) or complete the Appointment Request Form Online Specialty Consultations International Patients Referring Physician? To refer an adult patient: (877) 441-DFCI (441-3324) To refer a pediatric patient: (888) PEDI-ONC (733-4662) or complete the Patient Referral Form

Treatment and Care

Pediatric Treatment Centers and Clinical Services Care Team Patient And Family Support Care Quality and Patient Safety Patient Stories For Survivors of Childhood Cancer Browse by Cancer Type A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

New Patient Guide

Appointments & Second Opinions

New Patient? For appointments or second opinions: Adults: (877) 442-DFCI (442-3324) Children: (888) PEDI-ONC (733-4662) or complete the Appointment Request Form Your Child's Care Team For International Patients Referring Physician? To refer an adult patient: (877) 441-DFCI (441-3324) To refer a pediatric patient: (888) PEDI-ONC (733-4662) or complete the Patient Referral Form

Home
Newsroom
In The News

In The News

Search In The News

Date Range

From:

To:

clear all

Archives

Email
Print
Share
Text

Highlight Glossary Terms

News tagged ‘MultipleMyeloma’ clear

Sorted by:
Date
Title

ASH 2012 Multiple Myeloma Update – Day Three: Early Morning Oral Session (Myeloma Beacon)
- December 10, 2012

At the American Society of Hematology's annual meeting, Dr. Nikhil Munshi presented results from a study of the antibody BHQ880, which targets DKK-1, a protein that inhibits bone formation and is overabundant in people with multiple myeloma.

Tags: Antibody, BasicResearch, MultipleMyeloma

Dr. Paul Richardson presented recent Phase 2 clinical trial results at the International Myeloma Workshop in Kyoto, Japan.

Tags: MultipleMyeloma

Targeted Cancer Drugs Keep Myeloma Patients Up And Running (NPR)
- February 18, 2013

Dr. Ken Anderson discusses new targeted medicines for the treatment of myeloma. Dr. Anderson is leading an international study to determine whether these new drugs could mean risky transplants aren't needed any more.

Tags: MultipleMyeloma, TargetedTherapy

Two Wars Against Cancer (New York Times)
- December 29, 2012

Kathryn Giusti, CEO and co-founder of the Multiple Myeloma Research Foundation, discusses her work with the organization and her successful stem cell transplant performed at Dana-Farber.

Tags: MultipleMyeloma, StemCellTransplant

Using Data To Treat Cancer And Drive Innovation (Fast Company)
- April 22, 2013

Dr. John Quackenbush discusses the collaboration of GenoSpace and the Multiple Myeloma Research Foundation to advance cancer research and development. GenoSpace provides tools for genomics research.

Tags: Genomics, MultipleMyeloma

Showing 1-5 of 5 items